Cerevel Therapeutics Holdings Overview
Cerevel Therapeutics Holdings Discounted Cash Flow
DCF Analysis for CERE.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.15
Current Fair Value
$3.15
↓ 93.0% Downside
Overvalued by 93.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison